These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 16081783

  • 1. IL-21 enhances tumor rejection through a NKG2D-dependent mechanism.
    Takaki R, Hayakawa Y, Nelson A, Sivakumar PV, Hughes S, Smyth MJ, Lanier LL.
    J Immunol; 2005 Aug 15; 175(4):2167-73. PubMed ID: 16081783
    [Abstract] [Full Text] [Related]

  • 2. Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin.
    Hayakawa Y, Kelly JM, Westwood JA, Darcy PK, Diefenbach A, Raulet D, Smyth MJ.
    J Immunol; 2002 Nov 15; 169(10):5377-81. PubMed ID: 12421908
    [Abstract] [Full Text] [Related]

  • 3. Cutting edge: novel priming of tumor-specific immunity by NKG2D-triggered NK cell-mediated tumor rejection and Th1-independent CD4+ T cell pathway.
    Westwood JA, Kelly JM, Tanner JE, Kershaw MH, Smyth MJ, Hayakawa Y.
    J Immunol; 2004 Jan 15; 172(2):757-61. PubMed ID: 14707044
    [Abstract] [Full Text] [Related]

  • 4. Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo.
    Wiemann K, Mittrücker HW, Feger U, Welte SA, Yokoyama WM, Spies T, Rammensee HG, Steinle A.
    J Immunol; 2005 Jul 15; 175(2):720-9. PubMed ID: 16002667
    [Abstract] [Full Text] [Related]

  • 5. IFN-dependent down-regulation of the NKG2D ligand H60 on tumors.
    Bui JD, Carayannopoulos LN, Lanier LL, Yokoyama WM, Schreiber RD.
    J Immunol; 2006 Jan 15; 176(2):905-13. PubMed ID: 16393975
    [Abstract] [Full Text] [Related]

  • 6. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.
    Diefenbach A, Hsia JK, Hsiung MY, Raulet DH.
    Eur J Immunol; 2003 Feb 15; 33(2):381-91. PubMed ID: 12645935
    [Abstract] [Full Text] [Related]

  • 7. Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts.
    Ogasawara K, Benjamin J, Takaki R, Phillips JH, Lanier LL.
    Nat Immunol; 2005 Sep 15; 6(9):938-45. PubMed ID: 16086018
    [Abstract] [Full Text] [Related]

  • 8. Expression of NKG2D and its ligand in mouse heart allografts may have a role in acute rejection.
    Feng L, Ke N, Ye Z, Guo Y, Li S, Li Q, Li Y.
    Transplant Proc; 2009 Dec 15; 41(10):4332-9. PubMed ID: 20005394
    [Abstract] [Full Text] [Related]

  • 9. Cutting edge: the minor histocompatibility antigen H60 peptide interacts with both H-2Kb and NKG2D.
    Cerwenka A, O'Callaghan CA, Hamerman JA, Yadav R, Ajayi W, Roopenian DC, Joyce S, Lanier LL.
    J Immunol; 2002 Apr 01; 168(7):3131-4. PubMed ID: 11907062
    [Abstract] [Full Text] [Related]

  • 10. CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer.
    Smyth MJ, Teng MW, Swann J, Kyparissoudis K, Godfrey DI, Hayakawa Y.
    J Immunol; 2006 Feb 01; 176(3):1582-7. PubMed ID: 16424187
    [Abstract] [Full Text] [Related]

  • 11. T cells gene-engineered with DAP12 mediate effector function in an NKG2D-dependent and major histocompatibility complex-independent manner.
    Teng MW, Kershaw MH, Hayakawa Y, Cerutti L, Jane SM, Darcy PK, Smyth MJ.
    J Biol Chem; 2005 Nov 18; 280(46):38235-41. PubMed ID: 16169855
    [Abstract] [Full Text] [Related]

  • 12. Blastocyst MHC, a putative murine homologue of HLA-G, protects TAP-deficient tumor cells from natural killer cell-mediated rejection in vivo.
    Tajima A, Tanaka T, Ebata T, Takeda K, Kawasaki A, Kelly JM, Darcy PK, Vance RE, Raulet DH, Kinoshita K, Okumura K, Smyth MJ, Yagita H.
    J Immunol; 2003 Aug 15; 171(4):1715-21. PubMed ID: 12902470
    [Abstract] [Full Text] [Related]

  • 13. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity.
    Diefenbach A, Jensen ER, Jamieson AM, Raulet DH.
    Nature; 2001 Sep 13; 413(6852):165-71. PubMed ID: 11557981
    [Abstract] [Full Text] [Related]

  • 14. Costimulation of multiple NK cell activation receptors by NKG2D.
    Ho EL, Carayannopoulos LN, Poursine-Laurent J, Kinder J, Plougastel B, Smith HR, Yokoyama WM.
    J Immunol; 2002 Oct 01; 169(7):3667-75. PubMed ID: 12244159
    [Abstract] [Full Text] [Related]

  • 15. m144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection.
    Cretney E, Degli-Esposti MA, Densley EH, Farrell HE, Davis-Poynter NJ, Smyth MJ.
    J Exp Med; 1999 Aug 02; 190(3):435-44. PubMed ID: 10430631
    [Abstract] [Full Text] [Related]

  • 16. NKG2D-independent suppression of T cell proliferation by H60 and MICA.
    Kriegeskorte AK, Gebhardt FE, Porcellini S, Schiemann M, Stemberger C, Franz TJ, Huster KM, Carayannopoulos LN, Yokoyama WM, Colonna M, Siccardi AG, Bauer S, Busch DH.
    Proc Natl Acad Sci U S A; 2005 Aug 16; 102(33):11805-10. PubMed ID: 16091471
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of NK cell activity through TGF-beta 1 by down-regulation of NKG2D in a murine model of head and neck cancer.
    Dasgupta S, Bhattacharya-Chatterjee M, O'Malley BW, Chatterjee SK.
    J Immunol; 2005 Oct 15; 175(8):5541-50. PubMed ID: 16210663
    [Abstract] [Full Text] [Related]

  • 18. Chimeric NKG2D modified T cells inhibit systemic T-cell lymphoma growth in a manner involving multiple cytokines and cytotoxic pathways.
    Zhang T, Barber A, Sentman CL.
    Cancer Res; 2007 Nov 15; 67(22):11029-36. PubMed ID: 18006849
    [Abstract] [Full Text] [Related]

  • 19. [Effects of NKG2D and its ligands RAE-1 and H60 on graft-versus-tumor response].
    Li XF, Chen Q, Ye YB, Fan LF, Chen MS, Li JY, Chen HQ, Chen SP, Zhou ZF.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb 15; 15(1):160-4. PubMed ID: 17490545
    [Abstract] [Full Text] [Related]

  • 20. Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection.
    Routes JM, Ryan S, Morris K, Takaki R, Cerwenka A, Lanier LL.
    J Exp Med; 2005 Dec 05; 202(11):1477-82. PubMed ID: 16314433
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.